Abstract
This industry report focuses upon the technology and market trends in the GPCRs target space. Given the central and essential role GPCRs occupy as a drug target class, it is important for industry participants to map the landscape in terms of both biological/technical aspects of the target class as well as the market/business metrics.
This report addresses the molecular details of GPCR biology and technologies for their analysis/screening as well as the market metrics and end-user trends operative in this target class
- Topics Covered in This Report
- Biology of GPCRs and Molecular Signaling Cascades Associated with GPCR Activation
- Technologies for Studying GPCRs
- GPCR Target Class Druggability
- Quantitative Market Metrics
- Market Sizing
- Intellectual Property (IP) landscape
- Primary Market Research Data (Qualitative and Quantitative Trends)
- GPCR Therapeutics Pipeline in Pharma and Biotech and Specific GPCR Targets Addressed
- Unmet Market Needs in the GPCRs Space
Table of Contents
- Chapter 1. Executive Summary
- Chapter 2. GPCR Biology and Technologies for Studying GPCRs
- GPCR Signaling Cascades/ Signal Transduction
- Orphan GPCRs (oGPCRs)
- Technologies for Studying GPCRs
- Technologies for Screening GPCRs
- Chapter 3. Market Analysis of the GPCRs Space
- Features of GPCRs that make them Top-Tier Drug Targets
- GPCR Druggability
- Market Survey Data and Analysis of Qualitative and
- Quantitative Trends in the GPCRs Space
- Quantitative Market Analysis-Market Sizing & Growth Rate
- Intellectual Property (IP) Trends that Impact GPCRs
- Chapter 4. GPCR Targets and Therapeutics Pipeline
- Appendix 1. IP as it Impacts GPCRs
- Appendix 2. Overview and Key Trends/ Themes in the GPCRs Space
- Appendix 3. GPCR Market Survey 2007 Reveals Important Market Metrics and Unmet Market Needs
- Appendix 4. GPCR Market Survey 2007 Raw Data
